For patients

Bladder pills and dementia risk

Dr. Fernando Gómez Sancha · ICUA

Published on YouTube: · Duration:

Dr. Fernando Gómez Sancha · YouTube

Language: English. Editorial classification in the patient catalog.

Bladder pills and dementia risk

Playback connects to YouTube. Your search query is not sent to the player.

Watch video on YouTube

About this video

Antimuscarinics for the bladder (solifenacin, oxybutynin, tolterodine…) block acetylcholine throughout the body: dry mouth, constipation, blurred vision and, in older people, cognitive decline. Studies link long-term use with a higher risk of dementia. Discuss it with your doctor.

Documented details and sources

Only details explicitly stated in the sources. Missing information does not mean it did not occur.

No clinical case details have been extracted for this video.

Original title and description on YouTube

Source checked: 2026-10-04.

Available transcript · English

Source: subtitles available on YouTube.

They may contain transcription or translation errors; check the explanation in the video.

  1. Side effects, there's a problem here. Anti-muscarinics block acetylcholine, not only in the bladder, but throughout the body, causing dry mouth, less saliva is produced, which is often very annoying, constipation, blurred vision, and in older people it can cause or contribute to cognitive decline. This last point is very important.
  2. There are studies linking the long term use of anticholinergics with an increased risk of dementia. It's not cause for alarm, but it's something you should know and discuss with your doctor.

Patient guide · Back to the library